The Latest Breaking News from CLPT

ClearPoint Neuro Q1 Earnings Call Highlights

ClearPoint Neuro (NASDAQ:CLPT) reported record first-quarter 2026 revenue and reaffirmed its full-year outlook, as management highlighted growth in its legacy neurosurgical device business and early contributions from the recently acquired IRRAflow product line. Chief Executive Officer Joe Burnett

MarketBeat · May 13

ClearPoint Neuro Shares Are Trading Higher Wednesday: What's Going On?

ClearPoint Neuro Inc. (NASDAQ:CLPT) shares are trading higher Wednesday after the company announced results from a Phase I-II clinical study evaluating its ClearPoint Prism Neuro Laser Therapy System.

Benzinga · Oct 8, 2025

Recap: ClearPoint Neuro Q1 Earnings

ClearPoint Neuro (NASDAQ:CLPT) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings ClearPoint Neuro beat estimated earnings by 15.0%, reporting an EPS of $-0.17 versus an estimate of $-0.2.

Benzinga · May 11, 2022